Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Page Not Found
Cart summary

You have no items in your shopping cart.

Notch Signaling Pathway & Mechanisms | Biorbyt

Notch Signaling Pathway

A comprehensive guide to juxtacrine cell-cell communication, γ-secretase cleavage, NICD translocation, and cell fate determination.

The Notch signaling pathway is a highly conserved cell signaling system present in most animals. Operating strictly through direct cell-to-cell contact, it is a master regulator of developmental biology.

Notch signaling is critical for cell-cell communication, controlling cell fate decisions, cellular proliferation, differentiation, and apoptosis. It dictates fundamental processes during embryonic development and continues to actively maintain tissue homeostasis, stem cell niches, and immune system function in adult tissues.

1. Notch Signaling Pathway Map

Unlike pathways that rely on diffusible ligands (like hormones or growth factors), the Notch pathway is juxtacrine. It relies entirely on the physical interaction between transmembrane receptors on one cell and transmembrane ligands on an adjacent cell.

Notch Signaling Pathway Image

2. The Core Cleavage Mechanism

The activation of the Notch pathway relies on a sequence of proteolytic cleavage events that ultimately release a transcription factor directly from the cell membrane into the nucleus.

1

Ligand-Receptor Interaction

The pathway begins with the physical interaction between Notch receptors (Notch1-4 in mammals) on the "receiving" cell membrane and membrane-bound ligands (primarily Jagged1/2 and DLL1/3/4) on the "sending" cell. This physical tension unmasks a cleavage site on the extracellular domain of the Notch receptor.

2

Proteolytic Cleavage (γ-Secretase)

Following an initial cleavage by ADAM metalloproteases, the transmembrane core of the Notch receptor is cleaved by the γ-secretase complex (which includes Presenilin). This critical enzymatic cut releases the active Notch Intracellular Domain (NICD) into the cytoplasm.

3

Nuclear Translocation & Transcription

The free NICD immediately translocates to the nucleus. There, it binds to the DNA-binding protein CSL (also known as RBP-Jκ) and recruits the co-activator Mastermind-like (MAML). This tri-protein complex displaces co-repressors and activates the transcription of Notch target genes, prominently including members of the Hes and Hey gene families.

3. Pathological Significance

Because it sits at the apex of cell fate determination, dysregulation of the Notch signaling pathway causes a wide variety of severe diseases.

Oncology & Leukemia: Aberrant activation of Notch (often through activating mutations in Notch1) is a primary driver of T-cell acute lymphoblastic leukemia (T-ALL). Furthermore, hyperactive Notch signaling promotes angiogenesis, stem cell renewal, and metastasis in numerous solid tumors, including breast and breast cancers.

4. Essential Target Antibodies & Proteins

To accurately map cell-cell communication and detect downstream transcriptional activation, Biorbyt offers a comprehensive catalog of highly validated primary antibodies targeting the core components of the Notch cascade.

Cat. Code Target Molecule Validated Applications
orb500788 Notch1 IF, IHC-Fr, IHC-P, WB
orb1411370 Jagged1 IF, IHC-P, WB
orb1805839 DLL4 ELISA, FA, FACS, In vivo
orb100523 Hes1 FC, ICC, IF, IHC-Fr, IHC-P
orb11306 Presenilin 1 FC, ICC, IF, IHC-Fr, IHC-P, WB

5. Pathway Inhibitors & Assays

Because the release of the active NICD requires precise proteolytic cleavage, the Notch pathway is highly targetable. Discover our highly selective γ-secretase inhibitors (GSIs) and quantification kits to modulate and validate your in vitro models.